Drug Approval | April 21, 2022
Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved
Subscribe To Our Newsletter & Stay Updated
